Antibody-Drug Conjugates

Sharma plans to add to the company's acquisitions

CPhI Worldwide 2015

Profile of a CEO: Piramal Chief shares M&A plans

By Fiona BARRY

Piramal chief executive Vivek Sharma won last week’s CPhI award for the pharma industry’s CEO of the year. spoke to Sharma about his plans for the CDMO the day after the jury’s unanimous decision.

Piramal acquires Kentucky-based CDMO for $30m

Piramal acquires Kentucky-based CDMO for $30m

By Zachary Brennan

India-based CMO Piramal has acquired US-based sterile injectable CDMO (contract development and manufacturing organization) Coldstream Laboratories for $30.65m.